Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $496.45, a high estimate of $564.00, and a low estimate of $414.00. Witnessing a positive shift, the ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Announcements included the MI440X GPU for on-prem enterprise deployments and a longer-term roadmap that includes rack-scale ...

Now, it’s worth noting Stock Advisor’s total average return is 966 % — a market-crushing outperformance compared to 194% for ...

Andrew Hill Investment Advisors reports that client portfolios achieved double digit gains during 2025. Review our defensive ...

Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for ...

Amazon ( AMZN +0.26%) continues to underscore the strength of its business and deliver fantastic growth for long-term ...

This stock is a great choice for cautious and aggressive investors.

Investing.com - Morgan Stanley upgraded Vertex Pharmaceuticals (NASDAQ:VRTX) from Equalweight to Overweight on Wednesday, raising its price target to $516.00 from $438.00. The new target represents ...

Hustle transforms subjective athletic impressions into verified statistics—creating transparent performance records that athletes, families, and recruiters can trust. Built for competitive youth ...

The Vertex Locator is a silicon microstrip detector which provides the LHCb experiment with high precision measurements of tracks and decay vertices. The VELO sensors are exposed to a radiation dose ...